FDA News

Latest News

US FDA logo | Credit: US Food and Drug Administration
FDA Approves AGENT DCB for In-Stent Restenosis

March 1st 2024

The approval of the AGENT Drug-Coated Balloon is based on the AGENT IDE trial and was announced by Boston Scientific on March 01, 2024.

FDA Accepts sBLA of Bimekizumab for 3 New Indications Including Psoriatic Arthritis
FDA Accepts sBLA of Bimekizumab for 3 New Indications Including Psoriatic Arthritis

February 28th 2024

FDA Announces Voluntary Recall of Eye Ointments Due to Sterility Concerns
FDA Announces Voluntary Recall of Eye Ointments Due to Sterility Concerns

February 27th 2024

US FDA logo in black over a white background. | Credit: US Food and Drug Administration
FDA Issues CRL for Roluperidone for Treatment of Negative Symptoms in Schizophrenia

February 27th 2024

FDA Accepts sBLA for Priority Review of Dupilumab for Uncontrolled COPD
FDA Accepts sBLA for Priority Review of Dupilumab for Uncontrolled COPD

February 23rd 2024

Video Interviews
Podcasts
Thumbnail featuring podcast hosts and logo for Diabetes Dialogue

More News

© 2024 MJH Life Sciences

All rights reserved.